Lungeforandringer Som det er tilfældet for andre alfa- interferoner, er der under behandling med Pegasys rapporteret om lungesymptomer, inklusive dyspnø, lungeinfiltrater, pneumoni og pneumonitis.
Pulmonary changes As with other alpha interferons, pulmonary symptoms, including dyspnoea, pulmonary infiltrates, pneumonia, and pneumonitis have been reported during therapy with Pegasys.